Double-blind trial of flumazenil in hemiballismus

J. Kulisevsky; A. Avila; M. L. Berthier; M. Barbanoj

doi:10.1097/00002826-199410000-00010

Double-blind trial of flumazenil in hemiballismus

J. Kulisevsky, A. Avila, M. L. Berthier, M. Barbanoj

Departament de Medicina

Producció científica: Contribució a revista › Article › Recerca › Avaluat per experts

4 Cites (Scopus)

Resum

Three patients with hemiballismus received intravenous flumazenil and placebo in a double-blind cross-over study aimed to investigate whether an antagonistic action at the level of the GABA-benzodiazepine receptors may improve choreoballistic movements. No clinical benefit was seen.

Idioma original	Anglès
Pàgines (de-a)	470-472
Revista	Clinical Neuropharmacology
Volum	17
Número	5
DOIs	https://doi.org/10.1097/00002826-199410000-00010
Estat de la publicació	Publicada - 1 de gen. 1994

Accés al document

10.1097/00002826-199410000-00010

Com citar-ho

@article{e4091aa31ce04d41800e5fc7687b2907,

title = "Double-blind trial of flumazenil in hemiballismus",

abstract = "Three patients with hemiballismus received intravenous flumazenil and placebo in a double-blind cross-over study aimed to investigate whether an antagonistic action at the level of the GABA-benzodiazepine receptors may improve choreoballistic movements. No clinical benefit was seen.",

keywords = "Flumazenil, GABA, GABA-benzodiazepine receptors, Hemiballismus",

author = "J. Kulisevsky and A. Avila and Berthier, {M. L.} and M. Barbanoj",

year = "1994",

month = jan,

day = "1",

doi = "10.1097/00002826-199410000-00010",

language = "English",

volume = "17",

pages = "470--472",

number = "5",

}

TY - JOUR

T1 - Double-blind trial of flumazenil in hemiballismus

AU - Kulisevsky, J.

AU - Avila, A.

AU - Berthier, M. L.

AU - Barbanoj, M.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Three patients with hemiballismus received intravenous flumazenil and placebo in a double-blind cross-over study aimed to investigate whether an antagonistic action at the level of the GABA-benzodiazepine receptors may improve choreoballistic movements. No clinical benefit was seen.

AB - Three patients with hemiballismus received intravenous flumazenil and placebo in a double-blind cross-over study aimed to investigate whether an antagonistic action at the level of the GABA-benzodiazepine receptors may improve choreoballistic movements. No clinical benefit was seen.

KW - Flumazenil

KW - GABA

KW - GABA-benzodiazepine receptors

KW - Hemiballismus

U2 - 10.1097/00002826-199410000-00010

DO - 10.1097/00002826-199410000-00010

M3 - Article

SN - 0362-5664

VL - 17

SP - 470

EP - 472

JO - Clinical Neuropharmacology

JF - Clinical Neuropharmacology

IS - 5

ER -

Double-blind trial of flumazenil in hemiballismus

Resum

Accés al document

Fingerprint

Com citar-ho